This report contains market size and forecasts of Prosthetic Heart Valve/ Artificial Heart Valve in global, including the following market information:
Global Prosthetic Heart Valve/ Artificial Heart Valve Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prosthetic Heart Valve/ Artificial Heart Valve Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Prosthetic Heart Valve/ Artificial Heart Valve companies in 2021 (%)
The global Prosthetic Heart Valve/ Artificial Heart Valve market was valued at 6800.8 million in 2021 and is projected to reach US$ 10510 million by 2028, at a CAGR of 6.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transcatheter Heart Valve Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prosthetic Heart Valve/ Artificial Heart Valve include Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc.(Abbott Laboratories Company), Boston Scientific Corporation, Livanova Plc, Symetis, Jenavalve Technology Inc., Cryolife Inc. and Ttk Healthcare Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prosthetic Heart Valve/ Artificial Heart Valve manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prosthetic Heart Valve/ Artificial Heart Valve Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Prosthetic Heart Valve/ Artificial Heart Valve Market Segment Percentages, by Type, 2021 (%)
Transcatheter Heart Valve
Tissue Heart Valve
Mechanical Heart Valve
Global Prosthetic Heart Valve/ Artificial Heart Valve Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Prosthetic Heart Valve/ Artificial Heart Valve Market Segment Percentages, by Application, 2021 (%)
Rheumatic Heart Disease
Congenital Heart Disease
Marfan Syndrome
Other
Global Prosthetic Heart Valve/ Artificial Heart Valve Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Prosthetic Heart Valve/ Artificial Heart Valve Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prosthetic Heart Valve/ Artificial Heart Valve revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prosthetic Heart Valve/ Artificial Heart Valve revenues share in global market, 2021 (%)
Key companies Prosthetic Heart Valve/ Artificial Heart Valve sales in global market, 2017-2022 (Estimated), (Units)
Key companies Prosthetic Heart Valve/ Artificial Heart Valve sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Edwards Lifesciences Corporation
Medtronic Plc
St. Jude Medical Inc.(Abbott Laboratories Company)
Boston Scientific Corporation
Livanova Plc
Symetis
Jenavalve Technology Inc.
Cryolife Inc.
Ttk Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional Devices
Autotissue Berlin Gmbh
Comed B.V.
Meril Life Sciences
Labcor Laboratório
HLT Inc.(A Bracco Group Company)
Medtronic
Edwards Lifesciences Corporation
Boston Scientific Corporation
Livanova Plc
St. Jude Medical, Inc.(An Abbott Laboratories Company)
Symetis Sa
Jenavalve Technology, Inc.
Cryolife, Inc.
TTK Healthcare Limited(A Ttk Group Company)
Colibri Heart Valve, Llc
Lepu Medical Technology Co., Ltd.
Braile Biomédica